Schizophrenia Trial, Recruiting NCT05185128 Sponsor: Loma Linda University Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT05185128
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adolescents between 12 and 18 years of age
  • People who have a confirmed diagnosis of Autism Spectrum Disorder (ASD), assessed using two specific diagnostic tools (confirm with trial site)
  • People who have been diagnosed with a schizophrenia-related condition, such as schizophrenia, schizophreniform disorder, schizoaffective disorder, or a related psychotic disorder, confirmed through a structured clinical interview
  • People whose verbal and overall thinking/reasoning abilities meet a minimum score on a standardised intelligence test (a score of 70 or above), to ensure the ability to participate in brain scanning
  • Typically developing adolescents with no psychiatric history may also be eligible to join as a comparison group, recruited from the general community

Who may not be able to join:

  • People with a significant medical or neurological condition that could affect brain scan results, such as epilepsy or a brain tumour
  • Typically developing adolescents who have any history of a psychiatric condition
  • People with anything that makes an MRI scan unsafe, such as a history of metal fragment injury, metal implants inside the body, current orthodontic braces, or non-removable retainers

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Aarti Nair, PhD, Loma Linda University

Phone: 9095588707

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Loma Linda University
Registry
ClinicalTrials.gov
Start date
1 February 2022
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

The Awareness of Social Inference Test (TASIT); The Social Attribution Task - Multiple Choice (SAT-MC, SAT-MC-II); The computerized Penn Emotion Identification Task (PennCNB)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov